EphB1-Mediated Transient Blood-Brain Barrier Opening Facilitates a Ferritin-Based Nanotherapeutic for Alzheimer's Disease.

Adv Sci (Weinh) · 2026 · PMC13335922 · PMID 42406553

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In contrast, mice in the treatment groups, particularly those treated with AFn‐DPZ, displayed a decreasing trend in swimming path length (Figure 6c ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.